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Pathogenic Roles of MicroRNA in 
the Development of Asthma
Xiaoyan Dong and Nanbert Zhong
Abstract
Asthma is a common and chronic inflammatory disease. Pathogenic mechanism 
underlying asthma is complicated. The inflammatory reactions in asthma have been 
recognized to involve mast cells, eosinophils, lymphocytes (T cells, B cells), macro-
phages, and dendritic cells. MicroRNA (miRNA, miR) is a group of small noncod-
ing RNAs with 21–25 nucleotides (nt) in length, which impact biologic responses 
through the regulation of mRNA transcription and/or translation. MicroRNAs are 
related to developmental processes of many immunologic diseases. Most stud-
ies showed that regulation of miRNAs to their targeting genes appears to play an 
important role in the development of asthma. This chapter has discussed altered 
expression of miRNAs in cells and tissues from patients with asthma, in order to 
better understand the mechanics of pathogenesis of asthma. In addition, the regula-
tion of miRNAs as a novel therapeutic approach will require a deeper understanding 
of their function and mechanism of action.
Keywords: microRNA asthma, inflammation reaction
1. Introduction
Pediatric asthma is a global problem. In the last decade, its incidence has highly 
increased, particular growing by 10% in China [1]. Etiologically, asthma attack, due 
to gene-environmental interactions, can also be induced by allergy factors, includ-
ing air pollution, pollen, fungi and dust mites, food, and so on [2]. As a chronic 
inflammatory disease and a polygenic hereditary disease, the mechanism of asthma 
is not clearly understood until now. The adaptive and innate immune system with 
the involvement of mast cells, eosinophils, lymphocytes (T cells, B cells), macro-
phages, and dendritic cells, even epithelial cells and structure cells, contributed to 
the inflammation reaction of asthma [3–5]. Moreover, change in the secretion of 
IgE and cytokines, including gamma-interferon (γ-IFN) and tumor necrosis factor 
(TNF-α), is important in asthma attacks [6–8]. As an immune regulator, microRNA 
(miRNA or miR) regulates on target gene mRNA and plays an important role in the 
development and pathogenesis of asthma.
MicroRNAs are a group of small nonprotein-coding RNAs that are 21–25 nucleo-
tides in length. They act as transcriptional regulators involved in many complex 
human disorders and in biological processes including cell proliferation and apoptosis 
[9, 10]. Childhood asthma susceptibility is associated with mutations in specific gene 
mRNA and/or their specific miRNA. For example, HLA-G has been identified as an 
asthma susceptibility gene [11], which was found to be the target gene of miR-148a, 
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miR-148b, and miR-152. Further support for the theory that miRNA changes may be 
the cause of childhood asthma. The specific genotype of children with asthma was 
related to the significant difference in allele polymorphism (SNP) of rs2910164G/C 
and rs2292832C/T of pre-miRNA [12]. It showed that miR-223 was involved in 
the maturation and function of neutrophil differentiation [13]. miR-27b-3p, miR-
513a-5p, and miR-22-3p were also indicated to have influenced dust mite-induced 
asthma by regulating its target gene [14, 15]. In a murine model of acute and chronic 
asthma study, abnormal expression of miRNAs including miR-146b, miR-223, 
miR-29b, miR-29c, miR-483, miR-5745p, miR-672, and miR-690 in asthma was 
miRNA Inflammatory 
response
Reaction and cell differentiate Reference
miRNA-223 Immune 
inflammatory 
response
Neutrophils mature and differentiate [13]
miRNA-146, 
miRNA-146a
Asthma, innate 
immune responses
Airway epithelium, NF-kappaB pathway [17, 18]
miRNA-147 Immune 
inflammatory 
response
TLR signaling pathway [19]
miRNA-145 Asthma Comparable to glucocorticoid treatment [20]
miRNA-155 Immune 
inflammatory 
response, asthma
TLR signaling pathway, regulation of allergic 
inflammation, macrophage inflammatory 
response, Th2 priming of dendritic cells
[21–24]
miRNA-21 Immune 
inflammatory 
response, asthma
TLR signaling pathway, NF-kB, IL-12p35 
polarization
[25–27]
miRNA-124 Allergy inflammation M2 phenotype of monocytic cells [28]
miRNA-148a, 
miR-148b, 
and miR-152
Asthma HLA-G [11, 29]
miRNA-126 Asthma Th2 response, airway hyperresponse [30]
let-7 Asthma Il-13, regulation of allergic inflammation [31–33]
miRNA-221 Asthma Mast cell activity regulates the production of 
cytokines
[34, 35]
miRNA-9 Asthma Regulates steroid-resistant airway 
hyperresponsiveness
[36]
miRNA-672, 
miRNA-143
Asthma Expression of metalloproteinase [37]
miR-19a Asthma Enhances proliferation of bronchial epithelial 
cells by targeting TGFbetaR2 gene
[38]
miRNA-203 Asthma Negatively regulates c-Abl, ERK1/2 
phosphorylation, and proliferation in smooth 
muscle cells
[39]
miRNA-133, 
miR-133a
Asthma Upregulation of Rhoa in bronchial smooth 
muscle cells
[40]
miR-192 Asthma Decreased expression in peripheral blood of 
asthmatic individuals undergoing an allergen 
inhalation challenge
[41]
Table 1. 
The relationship of miRNA and inflammation response.
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detected [16]. It was found that miRNA plays an important role in regulating immune 
pathway(s). A lot of studies have focused on the relationship between miRNA and 
asthma during decades, which involved not only in inflammation cells and cytokines 
but also in the treatment of glucocorticoids (Table 1). In this chapter, we discuss the 
relationship of miRNAs to their targeted mRNA(s) involved in the inflammation cell 
in asthma, in order to review the pathogenic mechanism of asthma.
2. miRNA in T cell and B cell
T cell and B cell play an important role in immune mechanism, especially innate 
and adaptive immunity, of asthma. As an immune regulator, miRNA influences on 
these two cells and regulates their proliferation and function. Many studies have 
been focused on the regulation of miRNA to T cell and B cell in order to clear the 
mechanism of asthma.
2.1 T cell, follicular helper T cells (TFH cells), and Th17
T follicular helper (Tfh) cells are essential for the formation of germinal cen-
ters (GCs). As a subset of CD4+, it mediates GC formation and maintenance and 
provides help to antigen-specific B cells during infection and vaccination. Th17 
cells have also been implicated in the pathogenesis of several autoimmune and 
inflammatory diseases [42–44]. Th17 cells also mediate immune responses that are 
involved in maintaining epithelial barrier integrity, and it has been widely sug-
gested that some cases of asthma may be caused by dysregulated Th17 responses 
[44, 45]. MiRNA also regulates the differentiation and function of these cells.
It was found that the miR-17-92 cluster’s increasing role in regulating the 
immune system is involved in innate and adaptive immunity, including B cells and 
subsets of T cells such as Th1, Th2, T follicular helper cells, regulatory T cells, mono-
cytes/macrophages, NK cells, and dendritic cells [46]. Moreover, the study found 
that the miR-17 approximately 92 cluster is a critical regulator of T cell-dependent 
antibody responses and follicular helper T cells’ (TFH cells) differentiation [47].
We knew that the relationship of miRNA and its target gene mRNA is not a one-
to-one correspondence. Target gene mRNA could be regulated by many miRNAs, or 
one miRNA could regulate a number of mRNAs. A study showed that some miRNAs 
with strong probability may induce miR-27b, miR-27a, miR-30c, miR-1, and miR-
141 or inhibit miR-20b, miR-93, miR-20a, miR-152, miR-21, and miR-106a in Th17 
differentiation by targeting negative or positive regulators of Th17 differentiation, 
respectively [48]. In a regulatory network model of murine T helper cell differentia-
tion, the miR-212~132 and miR-182~183 clusters were significantly upregulated, 
and the overall miR-106~363 cluster was downregulated, which predicted to affect 
Th17 cell differentiation. In vitro, when miR-18b, miR-106a, and miR-363-3p were 
transfected into primary murine Cd4(+) lymphocytes, the expression of retinoid-
related orphan receptor c (Rorc), Rora, IL17a, and IL17f and abolished secretion of 
Th17-mediated interleukin-17a (IL17a) have declined [49].
In addition, miR-18a directly targeted Smad4, Hif1a, and Rora in the Th17 cell gene 
expression program. All of these reveal that activating signals influence the outcome 
of Th cell differentiation via differential regulation of mature microRNAs within a 
common cluster [50]. miR-18a was the most dynamically upregulated microRNA of 
the miR-17-92 cluster during Th17 cell differentiation. Based on which, the involve-
ment of miR-18a in the regulation of T-cell differentiation was demonstrated.
miR-155, as an important regulator in asthma, was involved in many path-
ways in allergy disease in Table 1. It was shown that the function in macrophage 
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inflammatory response [23] is differentially expressed in allergic T cells exposed 
to DM extract compared to in nonallergic cells. The level of miR-155 expression 
was positively associated with the expression of the TH2 cytokines IL-5 and IL-13. 
When miR-155 was inhibited by glucocorticoids in Jurkat T cells, then the produc-
tion of these cytokines were inhibited [51].
Several differentially expressed miRNAs in asthma, such as miRNA-34/449, 
let-7, miRNA-19, miRNA-21, and miRNA-455, were identified in various cell types 
and tissues including epithelial cells, T cells, type 2 innate lymphoid cells, lung tis-
sues, and smooth muscles. These miRNAs are involved in epithelial differentiation, 
mucus production, airway remodeling, and inflammation as well [52]. miR-146a 
has been shown to modulate T-cell immunity as well as enhance class switch and 
secretion of IgE in B cells by upregulating 14-3-3 sigma expression [53].
2.2 miRNA regulates B cell
B cells play a critical role in immune responses, but the regulation of microRNAs 
to B-cell proliferation and function was partially understood. Not only miR-17-92 
cluster was involved in B cell [46], but miR-146a also enhances class switch and 
secretion of IgE in B cells [53]. As an important immune regulatory cell, thrombo-
spondin 1 (TSP1)-producing B cells were regulated by miRNAs as well. miR-98 can 
suppress the expression of TSP1 in the peripheral B cells of patients with allergic 
asthma [54]. Further study revealed that overexpression of miR-29b in human B 
cells precipitated a reduction in overall AID protein whose activity affected the 
function of class-switch recombination (CSR) and then results in corresponding 
diminution in CSR to IgE [55].
3. miRNA and mast cell
It is essential that mast cells have major effector and immune regulatory 
functions in IgE-associated allergic diseases or in innate and adaptive immune 
responses. But their mechanism was not clear yet. miRNAs provide an additional 
layer in the regulation of gene expression acting as repressors with several targets 
at the posttranscriptional level. Several studies showed that miRNA expression 
patterns during differentiation and activation of mast cells. The expression of many 
miRNAs changes following IgE-FcepsilonRI cross-linking in activated mast cells. 
Upregulated expression of miR-221 promotes IgE-mediated activation of mast 
cell degranulation by PI3K/Akt/PLCgamma/Ca2+ signaling pathway, in a non-NF-
kappaB-dependent manner [56]. Downregulation of miR-223 promotes degranula-
tion via the PI3K/Akt pathway by targeting IGF-1R in mast cells [57]. In cockroach 
allergen model of asthma, when miRNA-33b was overexpressed, mast cell degranu-
lation was inhibited through suppression of the calcium release and IgE-FcepsilonRI 
pathway [58]. In line with this, neutralization of miR-132 by anti-miR inhibitor 
leads to sustained production of HB-EGF protein in activated mast cells [59].
Cytokine is also related to miRNA and mast cells in inflammation response of 
asthma. The treatment of IL-10 has been shown to suppress TNF production in 
mast cells. IL-10 effects are dependent on Stat3 activation, eliciting miR-155 expres-
sion, with a resulting loss of suppressor of cytokine signaling-1 [60]. miR-221, 
which was overexpressed in a murine asthma model, stimulated IL-4 secretion in 
mast cells through a pathway involving PTEN, p38, and NF-kappaB [61]. miR-223 
reduces IL-6 secretion in mast cells by inhibiting the IGF1R/PI3K signaling pathway 
[62]. Mex-3B, an antisense oligonucleotide targeting, directly upregulates IL-33 
expression by inhibiting miR-487b-3p-mediated repression of IL-33 [63].
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4. miRNA and dendritic cells
Dendritic cells (DCs) are the professional antigen-presenting cells (APCs) in the 
lung. They are found to be crucial in the induction and maintenance of allergic asthma 
by cross-linking innate and adaptive immune responses. After transfection with miR-
23b reagents, DCs were evaluated for endocytic ability, surface marker expression, 
cytokine secretion, and CD4+ T-cell differentiation. The study proved that miR-23b 
is capable of inducing tolerogenic DC activity and Treg responses in vitro through the 
inhibition of the Notch1 and NF-kappaB signaling pathways; thus, miR-23b might 
represent a therapeutic target for the management of allergic diseases [64].
miR-155 has been shown to be a crucial regulator of the immune system 
mentioned above. Not only miR-155 can influence on T cell function but also 
regulate the activity of DCs. Deficiency of miR-155 on DCs was also associated 
with impaired purinergic receptor signaling and alleviates AAI by diminishing Th2 
priming capacity and ATP-/P2R-induced activation of DCs in mice [24].
5.  miRNA and inflammatory phenotype (neutrophilic asthma and 
eosinophilic asthma)
Asthma may be classified according to severity and inflammatory phenotype 
and is likely to be distinguished by specific microRNA (miRNA) expression pro-
files. The study of miRNA expression in sputum supernatants with the inflamma-
tory cells in severe asthma was taken out. Expression of miR-629-3p, miR-223-3p, 
and miR-142-3p was significantly upregulated in the sputum of patients with severe 
asthma compared with that in healthy control subjects and was highest in patients 
with neutrophilic asthma. It suggested that these miRNAs are related to asthma 
inflammatory phenotype [65].
Single-nucleotide polymorphisms (SNPs) in miRNAs could affect their effi-
ciency in binding to messenger RNAs (mRNAs), which was taken little into account 
before. In a study in Korean population, it showed that the CT/CC genotype of 
miR-196a2 at locus rs11614913 was associated with eosinophilic asthma and a higher 
sputum eosinophil count than the TT genotype. The CG/GG genotype at rs2910164 
of miR-146a had a hyperresponsiveness in airway compared with the CC genotype. 
The AG/GG genotype at rs3746444 of miR-499 manifested higher predicted values 
of forced expiratory volume in 1 s (%FEV1) than the AA genotype [66].
A study about evaluating clinical potential of plasma miR-21 and miR-146a 
involved in T helper cell differentiation in childhood asthma found that the levels 
of miR-21 and miR-146a were not only positively correlated with eosinophil 
percentage but also associated with FEV1. miR-21 and miR-146a are upregulated 
in asthmatic children. miR-21 and miR-146a play a role in eosinophilic endotypic 
classification of asthma [67]. Moreover, its data show that miR-185-5p profile in 
eosinophils can be used as asthma diagnosis biomarker in serum and that this 
profile is able to rank asthma severity [68].
6. miRNA and macrophage
Monocytes and macrophages are important roles of the immune system, which 
possess pleiotropic effector and immunoregulatory functions. Classical activation 
(M1) and alternative activation (M2) of macrophages are necessary in the func-
tion. M1 polarization of macrophages results in the production of proinflammatory 
cytokines and antimicrobial and tumoricidal activity, whereas M2 polarization 
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of macrophages is related to immunosuppression, tumorigenesis, wound repair, 
and elimination of parasites [69]. It also reveals that miRNAs were involved in M 
macrophages’ activity. miR-511 is increased in macrophages following IL-4 and 
IL-13 stimulation and decreased in M1 macrophages both in vitro and in vivo [70]. 
Particularly, miR-9, miR-127, miR-155, and miR-125b have been shown to promote 
M1 polarization, while miR-124, miR-223, miR-34a, let-7c, miR-132, miR-146a, 
and miR-125a-5p may induce M2 polarization in macrophages by targeting various 
transcription factors and adaptor proteins. Differentiation of monocytes to macro-
phages is inhibited by miR-24, miR-30b, miR-142-3p, and miR-199a-5p. MiR-155 
and miR-142-3p inhibit macrophage proliferation, compared to let-7a. Interestingly, 
miR-155 has both pro- and antiapoptotic roles, whereas miR-21 and let-7e nega-
tively regulate macrophage apoptosis [69, 71, 72]. These data revealed that the 
function of miRNAs in modulating macrophage polarization may have potential 
way in the treatment of inflammation-related diseases.
On the other hand, studying the development of allergy disease in maternal 
pregnancy revealed that the embryonic development is highly sensitive to xeno-
biotic toxicity. If exposed to environmental toxins in utero, it affects physiological 
responses of the progeny. In the animal model, there was a lower expression of miR-
130a and increased expression of miR-16 and miR-221 in the lungs of mice which 
were exposed to sidestream cigarette smoke (SS) or secondhand smoke exhibit. 
These miRNAs regulate HIF-1 alpha-regulated apoptotic, angiogenic, and immune 
pathways. This process will lead to increase incidence of allergic asthma (AA) and 
bronchopulmonary dysplasia (BPD) in the progenies [73].
Besides, the expression of miRNAs was different in fungal bioaerosols which 
are ubiquitous in the environment, and human exposure can result in a variety of 
health effects ranging from systemic, subcutaneous, and cutaneous infections to 
respiratory morbidity including allergy, asthma, and hypersensitivity pneumonitis. 
It was found that miRNAs were involved in the inflammatory stimuli exposure to 
fungal. In studies of exposures to fungi (such as Aspergillus fumigatus, Candida 
albicans, and Cryptococcus neoformans), it was revealed that several miRNAs that 
were shared between responses to these species including miR-125 a/miR-125 b, 
miR-132 [43], miR-146a, and miR-29a/miR-29b were also involved in macrophage 
polarization/activation, TLR-mediated signaling, natural killer cell function, 
C-leptin signaling, and inhibition of Th1 immune response, respectively [74]. On 
the other hand, miR-487b can suppress the levels of mRNA and protein for IL-33, 
which plays an important role in macrophage activation for innate host defense and 
proinflammatory responses during the differentiation of bone marrow-derived 
macrophages (BMDMs) [75].
In summary, miRNAs exert their effect by binding to complementary nucleotide 
sequences of the targeted messenger RNA, thus forming an RNA-induced silencing 
complex. miRNAs play important roles in many aspects of macrophage biology and 
thereby affect many biological and pathological conditions, like monocyte dif-
ferentiation and development, macrophage polarization, infection, tumor growth, 
inflammatory activation, and so on [71, 72]. Numerous studies have demonstrated 
the important role of miRNA in the pathogenesis of childhood asthma, suggesting 
that miRNA plays a regulatory role between genes and the environment as well as 
allergic airway inflammation. The mechanism of miRNA activity involves a large 
number of miRNAs, which take mRNA with multiple functions as target genes and 
synergistically regulate multiple aspects of complex pathophysiological processes 
in childhood asthma. The role of miRNAs in inflammation cells is important in 
both innate and acquired immunity in which T cell, B cell, mast cells, macro-
phages, and dendritic cells are involved. The role of miRNAs in these cell types, 
miR-17-92 cluster, miR-221, miR-223, miR-146a, and miR-155, may be crucial 
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(Figure 1). Depending on these roles of miRNAs in dendritic cells, mast cells, and 
macrophages, we speculate about possible future directions in the field [76]. It is 
likely variant miRNAs form a network in which these miRNAs may interact with 
each other and alter the expression of target genes in the inflammation process of 
pediatric asthma. On the other hand, it is envisaged that targeted manipulation of 
specific miRNAs could be developed as a new treatment for asthma. At present, our 
group has already had some result about the relationship of miRNA to target gene in 
dust mite-induced asthma. Depending on this review, further investigation should 
be pursued on the immune regulatory function of miRNA in children’s asthma.
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Figure 1. 
miR-17-92 cluster, miR-221, miR-223, miR-146a, and miR-155 are associated with inflammation cells. (A) 
Downregulation of miR-223 promotes degranulation via the PI3K/Akt pathway by targeting IGF-1R and reduces 
IL-6 secretion in mast cells. It also induced M2 polarization. (B) miR-221 promoted IgE-mediated activation 
of mast cells degranulation by PI3K/Akt/PLCgamma/Ca2+ signaling pathway and stimulated IL-4 secretion 
in mast cells through a pathway involving PTEN, p38, and NF-kappaB. (C) miR-17~92 cluster as a critical 
regulator of T-cell-dependent antibody responses and follicular helper T cell (TFH cell) and Th17 differentiation. 
It enhances class switch and secretion of IgE in B cells. (D) miR-146 modulated T-cell immunity and enhanced 
class switch and secretion of IgE in B cells. miR-146a played a role in eosinophilic endotypic classification of 
asthma. It induced M2 polarization as well. (E) miR-155 was associated with Th2 cell and cytokine secretion. 
Deficiency of miR-155 on DCs was also related to impaired purinergic receptor signaling and alleviates AAI by 
diminishing Th2 priming capacity and ATP-/P2R-induced activation of DCs. It promoted M1 polarization.
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